Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A note on CYP2J2-mediated terfenadine hydroxylation in human liver microsomes.

Lu J, Qin X, Liu M, Wang X.

Food Chem Toxicol. 2014 Sep;71:284-5. doi: 10.1016/j.fct.2014.07.001. Epub 2014 Jul 2. No abstract available.

PMID:
24997310
2.

Response to comment: "A note on CYP2J2-mediated terfenadine hydroxylation in human liver microsomes".

Lee B, Wu Z, Liu KH.

Food Chem Toxicol. 2014 Sep;71:286-7. doi: 10.1016/j.fct.2014.07.002. Epub 2014 Jul 3. No abstract available.

PMID:
24998194
3.

Potential of decursin to inhibit the human cytochrome P450 2J2 isoform.

Lee B, Wu Z, Sung SH, Lee T, Song KS, Lee MY, Liu KH.

Food Chem Toxicol. 2014 Aug;70:94-9. doi: 10.1016/j.fct.2014.04.020. Epub 2014 Apr 29.

PMID:
24788058
4.

Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.

Lee E, Wu Z, Shon JC, Liu KH.

Drug Metab Dispos. 2015 Aug;43(8):1250-3. doi: 10.1124/dmd.115.064345. Epub 2015 Jun 5.

5.

Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.

Lee CA, Jones JP 3rd, Katayama J, Kaspera R, Jiang Y, Freiwald S, Smith E, Walker GS, Totah RA.

Drug Metab Dispos. 2012 May;40(5):943-51. doi: 10.1124/dmd.111.043505. Epub 2012 Feb 10.

6.

Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy.

Karkhanis A, Hong Y, Chan ECY.

Biochem Pharmacol. 2017 Jul 1;135:12-21. doi: 10.1016/j.bcp.2017.02.017. Epub 2017 Feb 23. Review.

PMID:
28237650
7.

In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.

Rodrigues AD, Mulford DJ, Lee RD, Surber BW, Kukulka MJ, Ferrero JL, Thomas SB, Shet MS, Estabrook RW.

Drug Metab Dispos. 1995 Jul;23(7):765-75.

PMID:
7587966
8.

Effect of crude extract of Eugenia jambolana Lam. on human cytochrome P450 enzymes.

Chinni S, Dubala A, Kosaraju J, Khatwal RB, Satish Kumar MN, Kannan E.

Phytother Res. 2014 Nov;28(11):1731-4. doi: 10.1002/ptr.5137. Epub 2014 Mar 4.

PMID:
24590863
9.
10.

Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations.

Yamazaki H, Okayama A, Imai N, Guengerich FP, Shimizu M.

Xenobiotica. 2006 Dec;36(12):1201-9.

PMID:
17162467
11.
12.

Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine.

Kishimoto W, Hiroi T, Sakai K, Funae Y, Igarashi T.

Res Commun Mol Pathol Pharmacol. 1997 Dec;98(3):273-92.

PMID:
9485522
13.

Comparison of CYP3A activities in a subclone of Caco-2 cells (TC7) and human intestine.

Raeissi SD, Guo Z, Dobson GL, Artursson P, Hidalgo IJ.

Pharm Res. 1997 Aug;14(8):1019-25.

PMID:
9279883
14.
15.

Identification of novel substrates for human cytochrome P450 2J2.

Lee CA, Neul D, Clouser-Roche A, Dalvie D, Wester MR, Jiang Y, Jones JP 3rd, Freiwald S, Zientek M, Totah RA.

Drug Metab Dispos. 2010 Feb;38(2):347-56. doi: 10.1124/dmd.109.030270. Epub 2009 Nov 18.

16.

Inhibitory effects of cedrol, β-cedrene, and thujopsene on cytochrome P450 enzyme activities in human liver microsomes.

Jeong HU, Kwon SS, Kong TY, Kim JH, Lee HS.

J Toxicol Environ Health A. 2014;77(22-24):1522-32. doi: 10.1080/15287394.2014.955906.

PMID:
25343299
17.

Inhibitors and inducers of CYP enzymes and P-Glycoprotein.

[No authors listed]

Med Lett Drugs Ther. 2016 Mar 28;58(1491):e46-7. No abstract available.

PMID:
27027691
18.

Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.

Jurima-Romet M, Wright M, Neigh S.

Br J Clin Pharmacol. 1998 Mar;45(3):318-21.

19.

Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes.

Hashizume T, Imaoka S, Mise M, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, Funae Y.

J Pharmacol Exp Ther. 2002 Jan;300(1):298-304.

20.

Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2.

Lafite P, Dijols S, Buisson D, Macherey AC, Zeldin DC, Dansette PM, Mansuy D.

Bioorg Med Chem Lett. 2006 May 15;16(10):2777-80. Epub 2006 Feb 21.

Supplemental Content

Support Center